期刊文献+

银杏叶片剂大鼠体内多成分序贯代谢研究 被引量:1

Sequential Metabolism Study on Ginkgo Folium Tablet in Digestive System
下载PDF
导出
摘要 目的以序贯代谢思想为指导,研究银杏叶片剂成分体内代谢动态情况。方法以在体大鼠封闭肠环法为研究手段,结合色谱指纹图谱,对银杏叶片剂经过口服消化系统空间顺序代谢,即肠道菌群、肠壁细胞及肝代谢后的入血成分谱进行考察及对比研究。结果对可检测到的色谱峰分析显示,银杏叶片剂有12个色谱峰在肠道内被肠道菌群代谢,经肠壁代谢产生7个色谱峰,银杏叶片剂中的成分大部分被肝代谢,3个原药色谱峰以原型入血。结论本研究对银杏叶片剂在口服途径不同代谢部位的情况进行了定性描述,可为该制剂的质量控制、机制阐述及再次开发提供参考。 Objective To investigate dynamic metabolism in vivo of Ginkgo Folium Tablet underthe guidance of sequential metabolism thoughts. Methods In situ closed-loop in rats was carriedout to study sequential metabolism of Ginkgo Folium Tablet through oral digestive system, namelyto investigate and compare the intestinal flora metabolism, the gut wall metabolism and hepaticmetabolism, combined with chromatographic fingerprint of blood samples. Results The analysisshowed that 12 peaks in Ginkgo Folium Tablet were metabolized by intestinal flora, and 7 peaksgenerated through the gut wall. Most components of Ginkgo Folium Tablet were metabolized inliver, and 3 original medicine components were directly into the blood. Conclusion This studyconducts a qualitative description of metabolism of Ginkgo Folium Tablet in different parts of theoral route, and provides references for the quality control, mechanism explanation and secondarydevelopment for Ginkgo Folium Tablet.
机构地区 北京中医药大学
出处 《中国中医药信息杂志》 CAS CSCD 2015年第7期78-82,共5页 Chinese Journal of Information on Traditional Chinese Medicine
基金 北京中医药大学大学生科研课题质量工程项目(201310026071)
关键词 银杏叶提取物片剂 序贯代谢 肝代谢 肠道菌群代谢 肠壁代谢 指纹图谱 封闭肠环法 Ginkgo Folium Tablet sequential metabolism hepatic metabolism intestinal florametabolism gut wall metabolism fingerprint in situ closed-loop
  • 相关文献

参考文献8

  • 1刘洋,潘艳丽,王晶娟,翟华强,张强,项佳媚,隗丽,杨文宁,关键雷,郭怡祯.多成分药物代谢理论及技术方法分析[J].中草药,2014,45(12):1663-1667. 被引量:19
  • 2De Feudis FV. A brief history of EGb 761R and its therapeuticuses[J]. Pharmacopsychiatry,2003,36(S1)丗2-7.
  • 3Mahadevan S, Park Y. Multifaceted therapeutic benefits of Ginkgobiloba L.丗chemistry, efficacy, safety, and uses[J]. Journal ofFood Science,2008,73(1)丗R14-R19.
  • 4Li L, Zhao Y, Du F, et al. Intestinal absorption and presystemicelimination of various chemical constituents present in GBE50extract, a standardized extract of Ginkgo biloba leaves[J].Current Drug Metabolism,2012,13(5)丗494-509.
  • 5Masaki K, Hashimoto M, Imai T. Intestinal first-pass metabolismvia carboxylesterase in rat jejunum and ileum[J]. Drug metabolismand disposition,2007,35(7)丗1089-1095.
  • 6Agar WT, Hird FJR, Sidhu GS. The absorption, transfer and uptakeof amino acids by intestinal tissue[J]. Biochimica et BiophysicaActa,1956,22(1):21-30.
  • 7Lv H, Wang G, Wu X, et al. Transport characteristics ofginkgolide B by Caco-2 cells and examination of ginkgolide B oralabsorption potential using rat in situ intestinal loop method[J].International Journal of Pharmaceutics,2008,351(1)丗31-35.
  • 8Luo Z, Liu Y, Zhao B, et al. Ex vivo and in situ approaches usedto study intestinal absorption[J]. Journal of Pharmacological andToxicological Methods,2013,68(2)丗208-216.

二级参考文献22

  • 1周兴旺.生物医学新兴学科与中药现代化——现代组合成分药物的研究[J].中草药,2007,38(3):321-326. 被引量:11
  • 2张治洲.从系统生物学到配伍西药:中药现代化的一个核心战略[J].中国生物工程杂志,2007,27(4):153-156. 被引量:4
  • 3Moldaver B L, Sakovan T M. Quantitative analysis of some multicomponent drug mixtures by thin-layer chromatography [J]. Farm Zh, 1968, 23(3): 28-33.
  • 4Mayell J S, Hiskey C F, Lachman L. Quantitative analysis of a multicomponent drug product using liquid chromatography [J]. Anal Chem, 1974, 46(3): 449-452.
  • 5Keith C T, Borisy A A, Stockwell B R. Multicomponent therapeutics for networked systems. [J]. Nat Rev Drug Discov, 2005, 4(1): 71-78.
  • 6Li P. Multi-component drug ADME/T and metabolic interactions [J]. CurrDrug Metab, 2011, 12(9): 808.
  • 7US Food and Drug Administration. Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations, Rockville [S/OL]. http://www.fda.gov/downloads/Drugs/Guidance Compliance RegulatoryInformation/Guidances/ucm292362. pdf. 2013-12- 11.
  • 8European Medicines Agency. Guideline on the Investigation of Drug Interactions [S/OL]. http://www. ema.europa.eu/docs/en_GB/document_library/Scientific_ guideline/2012/07/WC500129606.pdf. 2013-12-/1.
  • 9Pelkonen O, Turpeinen M, Uusitalo J, et al. Prediction of drug metabolism and interactions on the basis of in vitro investigations [J]. Basic Clin Pharmacol Toxicol, 2005, 96(3): 167-175.
  • 10国家中医药管理局关于印发中医药事业发展“十二五”规划的通知(国中医药规财发[2011]49号)[EB/OL].北京:国家中医药管理局,http://www.satcm.gov.crdweb2010/zhengwugongkai/jihuaguihua/zhuanxiangguihua/2012-06-.06/15737.html.2014-02-18.

共引文献18

同被引文献25

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部